Evidence map›Paper›PMID 24899188›Full record

ArticleJournal of virology2014

Disease severity is associated with differential gene expression at the early and late phases of infection in nonhuman primates infected with different H5N1 highly pathogenic avian influenza viruses.

Yukiko Muramoto, Jason E Shoemaker, Mai Quynh Le, Yasushi Itoh, Daisuke Tamura, Yuko Sakai-Tagawa, Hirotaka Imai, Ryuta Uraki, Ryo Takano, Eiryo Kawakami and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 55 citations in OpenAlex.

  1. Trial
  2. Article
  3. Deliberating the scientific evidence base for influenza transmission to raw milk consumers.Risk analysis : an official publication of the Society for Risk Analysis · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 3 countries.

Yukiko MuramotoDivision of Virology, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
Jason E ShoemakerERATO Infection-Induced Host Responses Project, Japan Science and Technology Agency, Saitama, Japan.
Mai Quynh LeNational Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
Yasushi ItohDepartment of Pathology, Shiga University of Medical Science, Ohtsu, Shiga, Japan.
Daisuke TamuraDivision of Virology, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
Yuko Sakai-TagawaDivision of Virology, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
Hirotaka ImaiDivision of Virology, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
Ryuta UrakiDivision of Virology, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
Ryo TakanoDivision of Virology, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
Eiryo KawakamiERATO Infection-Induced Host Responses Project, Japan Science and Technology Agency, Saitama, Japan.
Mutsumi ItoDivision of Virology, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
Kiyoko OkamotoDepartment of Pathology, Shiga University of Medical Science, Ohtsu, Shiga, Japan.
Hirohito IshigakiDepartment of Pathology, Shiga University of Medical Science, Ohtsu, Shiga, Japan.
Hitomi MimuroDivision of Bacteriology, Department of Infectious Diseases Control, International Research Center for Infectious Diseases, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
Chihiro SasakawaDivision of Bacterial Infection Biology, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan Nippon Institute for Biological Science, Ome, Tokyo, Japan Medical Mycology Research Center, Chiba University, Chuo-ku, Chiba, Japan.
Yukiko MatsuokaERATO Infection-Induced Host Responses Project, Japan Science and Technology Agency, Saitama, Japan.
Takeshi NodaDivision of Virology, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
Satoshi FukuyamaERATO Infection-Induced Host Responses Project, Japan Science and Technology Agency, Saitama, Japan.
Kazumasa OgasawaraDepartment of Pathology, Shiga University of Medical Science, Ohtsu, Shiga, Japan.
Hiroaki KitanoERATO Infection-Induced Host Responses Project, Japan Science and Technology Agency, Saitama, Japan The Systems Biology Institute, Tokyo, Japan Division of Systems Biology, Cancer Institute, Tokyo, Japan Sony Computer Science Laboratories, Inc., Tokyo, Japan Okinawa Institute of Science and Technology, Okinawa, Japan.
Yoshihiro KawaokaDivision of Virology, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan ERATO Infection-Induced Host Responses Project, Japan Science and Technology Agency, Saitama, Japan Department of Special Pathogens, International Research Center for Infectious Diseases, Institute of Medical Science, The University of Tokyo, Tokyo, Japan Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA kawaoka@ims.u-tokyo.ac.jp.
The University of Tokyo · JPJapan Science and Technology Agency · JPShiga University of Medical Science · JPNational Institute Of Hygiene And Epidemiology · VNNational Institute of Infectious Diseases · JPNippon Institute for Biological Science · JPSystems Biology Institute · JPUniversity of Wisconsin–Madison · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledOccasional transmission of highly pathogenic avian H5N1 influenza viruses to humans causes severe pneumonia with high mortality. To better understand the mechanisms via which H5N1 viruses induce severe disease in humans, we infected cynomolgus macaques with six different H5N1 strains isolated from human patients and compared their pathogenicity and the global host responses to the virus infection. Although all H5N1 viruses replicated in the respiratory tract, there was substantial heterogeneity in their replicative ability and in the disease severity induced, which ranged from asymptomatic to fatal. A comparison of global gene expression between severe and mild disease cases indicated that interferon-induced upregulation of genes related to innate immunity, apoptosis, and antigen processing/presentation in the early phase of infection was limited in severe disease cases, although interferon expression was upregulated in both severe and mild cases. Furthermore, coexpression analysis of microarray data, which reveals the dynamics of host responses during the infection, demonstrated that the limited expression of these genes early in infection led to a failure to suppress virus replication and to the hyperinduction of genes related to immunity, inflammation, coagulation, and homeostasis in the late phase of infection, resulting in a more severe disease. Our data suggest that the attenuated interferon-induced activation of innate immunity, apoptosis, and antigen presentation in the early phase of H5N1 virus infection leads to subsequent severe disease outcome. IMPORTANCE: Highly pathogenic avian H5N1 influenza viruses sometimes transmit to humans and cause severe pneumonia with ca. 60% lethality. The continued circulation of these viruses poses a pandemic threat; however, their pathogenesis in mammals is not fully understood. We, therefore, investigated the pathogenicity of six H5N1 viruses and compared the host responses of cynomolgus macaques to the virus infection. We identified differences in the viral replicative ability of and in disease severity caused by these H5N1 viruses. A comparison of global host responses between severe and mild disease cases identified the limited upregulation of interferon-stimulated genes early in infection in severe cases. The dynamics of the host responses indicated that the limited response early in infection failed to suppress virus replication and led to hyperinduction of pathological condition-related genes late in infection. These findings provide insight into the pathogenesis of H5N1 viruses in mammals.

Indexed as

AnimalsAntigen PresentationApoptosisCells, CulturedDogsGene ExpressionGene Expression Regulation, ViralHumansImmunity, InnateInflammationInfluenza A Virus, H5N1 SubtypeMacacaMacaca fascicularisMadin Darby Canine Kidney CellsOrthomyxoviridae InfectionsPrimates

Identifiers

PMID24899188
PMCPMC4136255
OpenAlexW1989047142

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.